Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Jason Thanh Lee, Ph.D.
Jason Thanh Lee, Ph.D.


Assistant Professor, Department of Molecular and Medical Pharmacology
Director, Crump Institute for Molecular Imaging, Preclinical Imaging Technology Center
Member, JCCC Cancer Molecular Imaging Program Area

Scientific Interest(s):

Dr. Jason Lee’s lab focuses on the development of in vivo molecular imaging techniques such as positron emission tomography (PET), computed tomography (CT) and optical (fluorescence and bioluminescence) imaging, and their applications for non-invasive assessment of cancer and associated biology. Specifically, Lee’s group studies preclinical imaging of cancer cell metabolism using tracers such as the glucose analog FDG and nucleoside analogs FAC and FLT, cell trafficking and activation using reporter genes, drug pharmacokinetic/pharmacodynamics and kinetic modeling.

Selected Cancer-Related Publications:

Nathanson DA, Armijo AL, Tom M, Li Z, Dimitrova E, Austin WR, Nomme J, Campbell DO, Ta L, Le TM, Lee JT, Darvish R, Gordin A, Wei L, Liao HI, Wilks M, Martin C, Sadeghi S, Murphy JM, Boulos N, Phelps ME, Faull KF, Herschman HR, Jung ME, Czernin J, Lavie A, Radu CG. Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication. J Exp Med. 2014 Mar 10;211(3):473-86. doi: 10.1084/jem.20131738. Epub 2014 Feb 24.

Murphy JM, Armijo AL, Nomme J, Lee CH, Smith QA, Li Z, Campbell DO, Liao HI, Nathanson DA, Austin WR, Lee JT, Darvish R, Wei L, Wang J, Su Y, Damoiseaux R, Sadeghi S, Phelps ME, Herschman HR, Czernin J, Alexandrova AN, Jung ME, Lavie A, Radu CG. Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography. J Med Chem. 2013 Sep 12;56(17):6696-708. doi: 10.1021/jm400457y. Epub 2013 Aug 15.

Lee JT, Campbell DO, Satyamurthy N, Czernin J, Radu CG. Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-Beta-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-Beta-L-arabinofuranosyl)-5-methylcytosine PET. J Nucl Med. 2012 Feb;53(2):275-80. doi: 10.2967/jnumed.111.090407.

Campbell DO, Yaghoubi SS, Su Y, Lee JT, Auerbach MS, Herschman H, Satyamurthy N, Czernin J, Lavie A, Radu CG. Structure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe. J Biol Chem. 2012 Jan 2;287(1):446-54. doi: 10.1074/jbc.M111.314666. Epub 2011 Nov 9.

Shu CJ, Campbell DO, Lee JT, Tran AQ, Wengrod JC, Witte ON, Phelps ME, Satyamurthy N, Czernin J, Radu CG. Novel PET probes specific for deoxycytidine kinase. J Nucl Med. 2010 Jul;51(7):1092-8. doi: 10.2967/jnumed.109.073361. Epub 2010 Jun 16.